The ROE as of November 2024 (TTM) for Accolade, Inc. (ACCD) is -18.43%

According to Accolade, Inc.’s latest financial reports and current stock price. The company's current ROE is -18.43%. This represents a change of 297.88% compared to the average of -4.63% of the last 4 quarters.

Accolade, Inc. (ACCD) Historical ROE (quarterly & annually)

How has ACCD ROE performed in the past?

The mean historical ROE of Accolade, Inc. over the last ten years is 18.17%. The current -18.43% ROE has changed -201.45% with respect to the historical average. Over the past ten years (40 quarters), ACCD's ROE was at its highest in in the May 2019 quarter at 99.66%. The ROE was at its lowest in in the May 2022 quarter at -64.14%.

Accolade, Inc. (ACCD) ROE by Quarter and Year

Discovering the peaks and valleys of Accolade, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Accolade, Inc. (ACCD) Average ROE

How has ACCD ROE performed in the past?

The current ROE of Accolade, Inc. (ACCD) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Accolade, Inc. (ACCD) ROE vs. Peers

How is ACCD’s ROE compared to its peers?

Accolade, Inc.’s ROE is less than Privia Health Group, Inc. (2.18%), less than HealthStream, Inc. (5.67%), less than National Research Corporation (67.40%), greater than Computer Programs and Systems, Inc. (-2.79%), less than NextGen Healthcare, Inc. (2.69%), greater than Health Catalyst, Inc. (-22.04%), greater than Definitive Healthcare Corp. (-50.72%), less than Premier, Inc. (7.08%), greater than Certara, Inc. (-2.96%), greater than Phreesia, Inc. (-39.34%), greater than Agiliti, Inc. (-3.07%), greater than Evolent Health, Inc. (-6.87%), greater than CareMax, Inc. (-682.67%), greater than R1 RCM Inc. (-2.18%),

Build a custom stock screener for Accolade, Inc. (ACCD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Accolade, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Accolade, Inc. (ACCD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Accolade, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.